Four Dow USA sites receive EXCiPACT GMP certification as pharmaceutical excipient suppliers

EXCiPACT asbl is pleased to announce that four Dow USA sites have each been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.   The Certificates demonstrate that the

  • Dow Midland Ethocel Operations site in Midland, Michigan, USA, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing of ethylcellulose (EC).
  • Dow Midland Methocel Operations site in Midland, Michigan, USA, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing, testing and release of methylcellulose (MC) and hydroxypropyl methylcellulose (HPMC) for use as pharmaceutical excipients.
  • Dow Polyox site in Institute, West Virginia, USA, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing of water-soluble polyethylene oxide polymers.
  • Dow LA Methocel operations site in Plaquemine, Louisiana, USA, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing of water-soluble methylcellulose and hydroxypropyl methylcellulose polymers for use as pharmaceutical excipient.

Go back